SPH zbycie akcji wĹasnych
Sofia, Bulgaria, September 24, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on September 23, 2020 the Company sold 5 000 own shares representing 0.0037% of the share capital of the Company, at a total value of BGN 15 700 on the Bulgarian Stock Exchange, the average price per share was 3.1400 BGN.
The total number of treasury shares after this transaction is 8 960 467, representing 6.647% of the share capital of the Company.
| Data | Tytuł | Kurs | Zmiana |
|---|
2024-04-25 | SPH Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format | 13,05 | 0,00 |
2024-04-22 | SPH Sales revenues of Sopharma AD for March 2024 | 13,70 | 0,00 |
2024-04-01 | SPH Presentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2022 | 13,40 | 0,00 |
2024-03-20 | SPH Sales revenues for February 2024 | 14,40 | -3,13 |
2024-03-12 | SPH Incoming transfer from capital increase subject to exercise of warrants from issue BG9200001212 | 14,00 | -1,43 |
2024-03-11 | SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase | 13,80 | +1,45 |
2024-02-29 | SPH Consolidated financial report as of 31 December 2023 | 13,70 | -2,19 |
2024-02-27 | SPH Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212 | 13,40 | +2,99 |
2024-02-22 | SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the acquisition of shares from a temporary issue/exercise of warrants | 13,75 | -0,73 |
2024-02-22 | SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the exercise of warrants in a capital increase under the condition | 13,75 | -0,73 |
